The Medical Science & PV Liaison (MSPVL) will provide and receive requested clinical and scientific information to and from members of the provider and payer community (private insurance, payers, medical groups, pharmacies, government agencies, and health systems with drug formularies), in compliance with all relevant company policies. The MSPVL will align with the Managed Market team to provide formulary support for product education. The MSPVL will participate in the strategic development and tactical execution of plans to engage payer opinion leaders (POLs) and act as a conduit for providing accurate and updated clinical, scientific, medical and safety information to Health Care Professionals and other members of the scientific community. MSPVL will also support day to day operations for both clinical drug safety and post-marketing pharmacovigilance (PV), with an emphasis on post-marketing surveillance for Rayaldee. Operations include ensuring proper processing of adverse events and safety information received from all sources, domestic and foreign, from intake to regulatory submission, for periodic aggregate reports and individual case safety reports. The MSPVL will assist in maintaining post-marketing database as well as the safety module within an electronic data capture system.
OPKO Health is a multi-national and diversified life science corporation that owns and operates a set of businesses offering biopharmaceutical, genetic testing, laboratory diagnostics, medical device, contract manufacturing, animal, supplement and nutritional health products and services in 60 plus countries with 5,000 employees.
|
QUALIFICATIONS |
|
SKILLS |
|
Software Powered by iCIMS
www.icims.com